These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11822245)
61. The foremost dilemma in managing a hospital formulary. Hoffmann RP Hosp Pharm; 1982 May; 17(5):245. PubMed ID: 10255244 [No Abstract] [Full Text] [Related]
62. Taking a seat at the table: what is a radiologist doing on the hospital formulary committee? Jaffe TA Acad Radiol; 2012 Dec; 19(12):1581-2. PubMed ID: 22884400 [No Abstract] [Full Text] [Related]
63. ASHP statement on the formulary system. Am J Hosp Pharm; 1986 Nov; 43(11):2839-41. PubMed ID: 3799624 [No Abstract] [Full Text] [Related]
64. ASHP statement on the formulary system. Am J Hosp Pharm; 1983 Aug; 40(8):1384-5. PubMed ID: 6614023 [No Abstract] [Full Text] [Related]
65. The evolution of an effective P & T Committee: advice from the chairman. Williams RR Hosp Formul; 1986 Dec; 21(12):1232-5, 1243. PubMed ID: 10279772 [TBL] [Abstract][Full Text] [Related]
66. Formulary submission process catches on ... slowly. Cross M Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856 [No Abstract] [Full Text] [Related]
67. Communicating P & T guidelines: how one committee meets the challenge. Dreyfus R; Bender F Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681 [TBL] [Abstract][Full Text] [Related]
68. Therapeutics committee and the hospital formulary. FRANCKE DE Bull Am Soc Hosp Pharm; 1948; 5(1):6-13. PubMed ID: 18863039 [No Abstract] [Full Text] [Related]
69. Experience with a hospital formulary. Bateson MC; Crooks J; Hamley JG; Leach R; MacConnachie A; Newton RW; Tudhope GR Health Bull (Edinb); 1981 Jan; 39(1):45-50. PubMed ID: 7216759 [No Abstract] [Full Text] [Related]
70. How to crack the $2 billion hospital market for pharmaceuticals. Zellmer WA Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527 [No Abstract] [Full Text] [Related]
71. P & T Committee role in advocating rational therapeutics. Borreson R Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625 [TBL] [Abstract][Full Text] [Related]
72. Cephalosporin selection: view from a beleaguered P & T committee member. Talley JH Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082 [TBL] [Abstract][Full Text] [Related]
73. P & T Committee problem-solving in a Canadian specialty hospital. Feld R Hosp Formul; 1986 Jul; 21(7):778-9, 783-4. PubMed ID: 10277344 [TBL] [Abstract][Full Text] [Related]
74. Developing a quick reference formulary. Huntzinger PE Mil Med; 2001 Oct; 166(10):881-3. PubMed ID: 11603239 [TBL] [Abstract][Full Text] [Related]
75. Rational drug use (II): Hospital drug and therapeutics committees. Manyemba J; Dzuda C; Nyazema NZ Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773 [No Abstract] [Full Text] [Related]
76. The case for a value-based formulary: striving for total lowest net cost. Weart W; Bauman GR Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330 [TBL] [Abstract][Full Text] [Related]
77. Developing an effective P&T Committee, Part I. Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920 [TBL] [Abstract][Full Text] [Related]
79. PSRO: will pharmacy and medicine now work together? Jeffrey LP Hosp Formul; 1975 Jun; 10(6):283-6. PubMed ID: 10273081 [No Abstract] [Full Text] [Related]
80. Formulary management. What is your institution's policy regarding formulary requests? Wein PJ Hosp Formul; 1989 May; 24(5):289. PubMed ID: 10292978 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]